When Ozempic And Wegovy Fail To Work- Why GLP-1 Drugs Aren’t The Magic Bullet For Everyone
Ozempic and Wegovy have received a lot of publicity as revolutionizing treatment options for obesity. Both medications form a class of GLP-1 receptor agonists, which mimic a hormone in the body called glucagon-like peptide-1 and are involved in the regulation of appetite and blood sugar. Indeed, in initial clinical studies, the majority of those on the drugs lost 15% to 22% of body weight, hence much optimism. For most patients, these medications are underwhelming for about 20% of patients due to minimal weight loss or other challenges.
Take a closer look at why the weight loss drugs may not work for everyone, together with what options exist when they don't deliver the expected outcomes.
While GLP-1 receptor agonists have produced phenomenal responses in a majority of patients, it remains a reality that these drugs work differently for different people. Here's why:
1. Genetic and Hormonal Variability
Weight loss medications interact with complex systems in the body that differ from person to person. Genetics, hormones, and individual brain responses to energy regulation play significant roles in determining how a person responds to drugs like Ozempic and Wegovy.
2. Underlying Medical Conditions
Other conditions, such as sleep apnea, may be prevalent and prevent or delay the achievement of weight loss goals. Prescription drugs like antidepressants, steroids, or contraceptives are other medications that can nullify weight loss medication benefits.
3. Unrealistic Expectations
Often, they come to these medications with enormous hopes; expecting the promised rapid and dramatic weight loss. Progress creates disappointment if it has not stalled. In patients who rigidly follow recommended lifestyle modifications, frustration and disappointment are most common.
For most patients, the effectiveness of GLP-1 receptor agonists is evident within a few weeks of treatment. Weight loss typically begins within a few weeks of initiating therapy and tends to increase with dosage. However, some patients respond very little, if at all, despite strict adherence to their regimen.
For nonresponders, this can feel like a dead end. However, understanding the unique complexities of obesity is essential. This condition stems from brain dysfunction, and the pathways that contribute to weight regulation differ among individuals.
When Ozempic or Wegovy doesn’t yield desired results, there are still many paths to explore:
For example, some patients who don't respond well to one GLP-1 receptor agonist might find success with another drug in the same class. Newer medications, such as Zepbound, target other hormone pathways and seem promising even for those not responsive to earlier drugs.
While there is much to say about newer drugs, older treatments can still be useful and work for some patients. One can also seek the help of a medical provider specializing in obesity treatments in order to identify the best alternatives.
Diet, exercise, sleep, and stress management continue to be integral components of any weight loss program. New changes may be small but can make an enormous difference in one's health and success.
It is a complex disorder, and most patients should receive a multidisciplinary treatment. Collaboration with an obesity-aware doctor may mean access to tailored treatment plans, ranging from psychological support all the way to metabolic testing, and many others.
For others, side effects like nausea, vomiting, or diarrhea hinder them from continuing with these drugs. These symptoms often reduce as the body becomes accustomed, but for some, they might be severe enough to stop treatment altogether. In those instances, alternative drugs or procedures become vital to find.
Another largely unexplored area relates to GLP-1 drugs' long-term effects on the brain's regulation of hunger and satiety. Although GLP-1 drugs suppress appetite and can lead to effective weight loss, emerging research suggests that they may also affect brain reward mechanisms, changing the way patients experience foods.
This aspect could prove of paramount significance in the future treatment of obesity. Perhaps GLP-1 receptor agonists do indeed affect and rewire the brain's reward pathways and will thus provide sustained benefits beyond discontinuation. However, more research is required to understand this phenomenon fully.
While for many, Ozempic and Wegovy have revolutionized obesity treatment, these are certainly not a one size fits all. Nonresponders need not lose hope- alternative strategies and medications abound. A consultation with an obesity expert healthcare provider is essential to put together a comprehensive, tailored treatment plan.
The route toward effective weight loss may be challenging, but with the evolution of obesity medicine and a better understanding of individual needs, there is a path forward for everyone.
Credits: Canva
As measles continues to spread across the United States, with recent case numbers climbing to their highest level in 33 years, growing numbers of Americans are becoming concerned about how at risk they may be.
Health officials in Philadelphia confirmed a potential measles exposure at Philadelphia International Airport and several public transport locations across the city in early January. The Centers for Disease Control and Prevention has also flagged earlier measles outbreaks across Pennsylvania, New Jersey, and New York City.
Adding to the concern, infectious disease tracker BMJGroup reported that measles cases recorded in 2025 are the highest seen since at least 1992.
Against this backdrop, it is important to understand whether measles can be fatal and to recognise the symptoms that should not be ignored.
Yes, measles can be deadly and carries a significant risk of death, according to the Centers for Disease Control and Prevention.
“Measles can lead to serious health complications, including pneumonia, inflammation of the brain known as encephalitis, and death,” the CDC states. “Between one and three out of every 1,000 people infected with measles will die. Around one in five people with measles will require hospital care, and one in every 20 children with measles develops pneumonia, which is the leading cause of measles-related deaths in young children.
“One in every 1,000 people with measles will experience brain swelling, which can result in permanent brain damage.”
According to the Mayo Clinic, measles symptoms usually appear in three distinct stages.
Stage 1: Incubation period (10 to 14 days)
During this phase, there are typically no noticeable or warning symptoms.
Stage 2: Early symptoms begin
Symptoms at this stage may include a dry cough, fever, red and inflamed eyes known as conjunctivitis, a runny nose, and a sore throat.
Stage 3: Acute illness and rash
“In the third stage, a rash begins to develop, usually starting on the face. Small white spots called Koplik spots may appear inside the mouth two to three days after symptoms first appear,” the Mayo Clinic explains. “The measles rash typically shows up three to five days after the initial symptoms.
“Over the following days, the rash spreads to the arms, torso, and legs. Alongside the rash, fever often rises rapidly and can exceed 105 degrees Fahrenheit,” the guidance continues. “Eventually, the fever subsides, and the rash fades from the body starting at the head and moving downward.”
“If individuals aged six months or older are exposed to measles and do not have immunity from prior infection or vaccination, they can receive the measles vaccine within three days of contact with the virus,” the Mayo Clinic advises. “After vaccination, quarantine at home is not required.
“For children up to 11 months old who are exposed and are not immune, a dose of antibodies known as immune globulin can be given within six days of exposure to help the body fight the infection.”
Receiving this antibody treatment requires a 21-day quarantine period.
CREDITS: CANVA
A notice has been issued for people who use the drug spironolactone. It is commonly prescribed for heart conditions, high blood pressure, and fluid retention. However, doctors say the medication is also used for several other health concerns.
According to the British Association of Dermatologists (BAD), spironolactone is prescribed “off licence” for women dealing with acne, female pattern hair loss, and hirsutism, a condition marked by excessive hair growth in areas such as the chin and upper lip. The NHS also states that spironolactone is a well-established and generally safe medicine that is sometimes used off licence to treat acne. Off licence means the drug is not officially approved for that specific condition under the UK prescribing licence.
Despite this, the NHS says spironolactone is available through the health service and is considered a useful alternative to long-term antibiotics. A study published in 2022 found that the drug is effective and safe for women who have persistent acne.
Spironolactone, sold under the brand name Aldactone, is also used to help manage polycystic ovary syndrome, commonly known as PCOS. However, it is not usually prescribed to men for skin-related conditions.
While the medication can be helpful for many women, experts warn that it does come with side effects and certain dietary restrictions. Here is what patients should know before starting treatment.
The NHS explains that spironolactone does not permanently cure acne, but it can help control breakouts and gradually clear the skin. The drug works slowly, meaning results are not immediate.
Most women begin to see improvement after about three months of use, but treatment usually needs to continue for at least six months. In some cases, it may take the full six months to experience the maximum benefit.
For acne, spironolactone is usually prescribed at doses ranging from 50mg to 150mg per day. Many patients start with 50mg daily for the first month, depending on how well they tolerate the medication and whether any side effects appear.
If there are no concerning side effects and blood test results remain normal, a doctor may increase the dose to 100mg per day. NHS guidance says the tablets should be swallowed whole with water and taken after food.
High potassium levels in the blood, especially in people over 45 or those with heart or kidney disease
Changes in kidney or liver blood tests, which usually return to normal if the dose is reduced or stopped
Cancer, which has been linked to very high doses in animal studies, but not seen in people taking standard doses.
The NHS advises that spironolactone should not be taken during pregnancy or while trying to conceive. It should also be avoided by people with Addison’s disease or serious kidney problems.
Alcohol can worsen certain side effects, such as dizziness, so cutting back on drinking is recommended. Reliable contraception should be used while taking spironolactone, and the combined contraceptive pill may help reduce side effects while also improving acne.
Doctors advise that it is usually safe to try for a baby one month after stopping the medication. The NHS stresses the importance of informing your doctor about any other medicines you are taking before starting spironolactone. This includes ACE inhibitors, anti-inflammatory painkillers such as aspirin or ibuprofen, certain antibiotics, other diuretics, heart medications like digoxin, drugs for high blood pressure, and potassium supplements.
As per Mirror, people taking spironolactone are advised not to use low-sodium salt or salt substitutes such as Lo-Salt, as these products contain high levels of potassium. Using them alongside spironolactone can raise potassium levels to a dangerous range.
The NHS also recommends limiting foods and drinks high in potassium, including bananas, avocados, pulses, nuts, and salmon. A doctor or dietitian can help plan a low-potassium diet if needed.
Disclaimer:
This article is for general information only and is not a substitute for medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, including spironolactone.
Credits: Canva
The NHS has issued advice for anyone taking a widely prescribed medication, warning of possible “serious” side effects. If you are currently on atorvastatin, it’s important to be cautious about what other medicines or supplements you take alongside it.
Atorvastatin belongs to a class of drugs called statins, which help lower cholesterol levels. It is usually prescribed for people with high cholesterol to reduce the risk of heart disease, including heart attacks and strokes.
Your GP may also recommend atorvastatin if you have a family history of heart disease or a long-term condition such as type 1 or type 2 diabetes or rheumatoid arthritis. As with any medicine, it’s vital to follow official guidance on how to take it safely.
On its website, the NHS lists certain “cautions with other medicines.” This means you should check that atorvastatin is safe to take alongside any other drugs or supplements.
The NHS explained: “Some medicines can affect the way atorvastatin works and can increase the chances of you having serious side effects, such as muscle damage.” You should tell your doctor or pharmacist if you are taking any of the following:
If you need to take one of these medicines while on atorvastatin, your doctor may:
These are not all the drugs that can interact with atorvastatin. “For a full list, see the leaflet in your medicine packet or speak to your pharmacist,” the NHS said.
The health service also advised checking with your doctor or pharmacist before taking supplements like St John’s wort or CoQ10 while on atorvastatin.
The NHS lists these common side effects, which affect more than one in 100 people:
“Drinking large amounts of alcohol regularly increases the risk of side effects and liver problems while taking atorvastatin,” the NHS added. “If side effects make you want to stop taking the medicine, speak to your doctor first. They may be due to another cause, and your doctor can suggest lowering the dose or switching medicines.”
Stop taking atorvastatin and contact a doctor or call 111 immediately if you experience:
© 2024 Bennett, Coleman & Company Limited